TRIJARDY XR 5-2.5-1,000 MG TAB

empagliflozin, linagliptin, metformin hydrochloride
$5.6418per EA

Strength

5; 2.5; 1000 mg/1; mg/1; mg/1

NDC

00597039582

Classification

Brand

Dosage Form

TABLET, EXTENDED RELEASE

Route

ORAL

Last Updated

1/1/2026

Approval Type

New Drug (NDA)

FDA Application

NDA212614

On Market Since

4/23/2020

Pharmacological Classes

Biguanide
Biguanides
Dipeptidyl Peptidase 4 Inhibitor
Dipeptidyl Peptidase 4 Inhibitors
Sodium-Glucose Cotransporter 2 Inhibitor
Sodium-Glucose Transporter 2 Inhibitors

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

-44.3%

1Y

-44.4%

3Y

-40.7%

5Y

N/A

All

-38.2%